Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
29.00
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Hisamitsu Pharmaceutical EPS Diluted (Quarterly) : 0.4542 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.5548 |
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1226 |
| AnGes, Inc. | -0.0052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 33.00M |
| Revenue (Quarterly) | 261.68M |
| Total Expenses (Quarterly) | 229.49M |
| Enterprise Value | 1.354B |
| Gross Profit Margin (Quarterly) | 58.48% |
| Profit Margin (Quarterly) | 12.61% |
| Earnings Yield | 6.32% |
| Operating Earnings Yield | 5.82% |
| Normalized Earnings Yield | 6.484 |